SSA
GMVD

Schonfeld Strategic Advisors’s G Medical Innovations Holdings Ltd. Ordinary Shares GMVD Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GMVD Stock Details GMVD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,914
Closed -$16K – 3190
2022
Q3 		$16K Sell
1,914
-1,546
-45% -$22.7K ﹤0.01% 2721
2022
Q2 		$73K Buy
3,460
+114
+3% +$3.6K ﹤0.01% 2185
2022
Q1 		$149K Sell
3,346
-220
-6% -$21.5K ﹤0.01% 2101
2021
Q4 		$208K Buy
3,566
+92
+3% +$6.86K ﹤0.01% 1710
2021
Q3 		$272K Buy
3,474
+188
+6% +$19.8K ﹤0.01% 1583
2021
Q2 		$422K Buy
+3,286
New +$417K ﹤0.01% 1275

Other funds holding GMVD

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HWM
HighMark Wealth Management St. Paul, Minnesota $246M AUM 35.95% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Schonfeld Strategic Advisors's GMVD Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) in Q4 2022, closing a stake of 1,914 shares — an estimated $16K sold.

Schonfeld Strategic Advisors first reported a position in GMVD in Q2 2021 and held it in 6 quarters. The position peaked at $422K in Q2 2021. 6 funds tracked by Wall St. Rank hold GMVD as of Q4 2022.

  • Schonfeld Strategic Advisors reported no remaining G Medical Innovations Holdings Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 1,914 G Medical Innovations Holdings Ltd. Ordinary Shares shares in Q4 2022, an estimated $16K.
  • Schonfeld Strategic Advisors first reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares in Q2 2021 and held it in 6 quarters.
  • Schonfeld Strategic Advisors's G Medical Innovations Holdings Ltd. Ordinary Shares position peaked at $422K in Q2 2021.
  • 6 funds tracked by Wall St. Rank held G Medical Innovations Holdings Ltd. Ordinary Shares as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.